Insider Transactions in Q1 2022 at Harvard Bioscience Inc (HBIO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2022
|
James W Green Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
302,402
+6.42%
|
-
|
|
Mar 01
2022
|
Michael A. Rossi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
59,737
+10.01%
|
-
|
|
Jan 01
2022
|
Alan I Edrick Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+1.85%
|
-
|
|
Jan 01
2022
|
Katherine A. Eade Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+1.24%
|
-
|
|
Jan 01
2022
|
James W Green Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
47,424
-2.34%
|
$331,968
$7.05 P/Share
|
|
Jan 01
2022
|
Thomas W Loewald Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,525
+1.34%
|
-
|
|
Jan 01
2022
|
Bertrand Loy Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,489
+1.51%
|
-
|